2008
DOI: 10.3748/wjg.14.3425
|View full text |Cite
|
Sign up to set email alerts
|

Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement

Abstract: CONCLUSION:Judicious use of en bloc PD and gastrectomy and strictly preventing postoperative complications may improve the long-term survival for advanced gastric cancer patients with pancreaticoduodenal region involvement. Well-differentiated histology and negative resection margin are the most important predictors of long survival.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
31
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 22 publications
(32 citation statements)
references
References 18 publications
0
31
0
1
Order By: Relevance
“…The number of patients known to have received adjuvant chemotherapy was 52. The chemotherapeutic regimens reported for adjuvant therapy were mitomycin C with 5-fluorouracil; etoposide, leucovorin, and 5-fluorouracil; and mitomycin C with tegafur [9,12,13]. Radiation therapy was not reported in any of the studies reviewed.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The number of patients known to have received adjuvant chemotherapy was 52. The chemotherapeutic regimens reported for adjuvant therapy were mitomycin C with 5-fluorouracil; etoposide, leucovorin, and 5-fluorouracil; and mitomycin C with tegafur [9,12,13]. Radiation therapy was not reported in any of the studies reviewed.…”
Section: Resultsmentioning
confidence: 99%
“…Six of the eight studies did not describe or report on staging investigations used prior to PD and gastrectomy [9][10][11][12][13]15]. Chan reported performing endoscopic ultrasound in 4 of 7 patients; pancreatic invasion was detected in one patient and was confirmed histologically [4].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations